RESPIRATORY DISEASES

Health Evidence Bulletins - Wales
Team Leader: Dr Michael Burr Date of completion: 8/9/97

The contents of this bulletin are likely to be valid for approximately one year, by which time significantly new research evidence may become available


9. Chronic Bronchitis and Emphysema - Non-drug management

(Users are advised to consult the supporting evidence for a consideration of all the implications of a recommendation)

The Statements The Evidence
9a. 76% of deaths from chronic bronchitis and emphysema in the United Kingdom (in 1995) were attributed to smokingi .

(Health gain notation - 6 "likely to be harmful")

and smoking cessation should be a key focus of future initiatives aimed at controlling this diseaseii.
(Health gain notation - 1" beneficial")
See the Healthy Living Bulletin in this series

i. Peto R, Lopez AD, Boreham J, Thun M, Heath C. Jr; Imperial Cancer Research Fund: World Health Organisation. Mortality from smoking in developed countries 1950-2000. Oxford: Oxford University Press, 1994. pp.528-529
(Type IV evidence - statistical information);
ii. Fiel BS. Chronic obstructive pulmonary disease. Mortality and mortality reduction. Drugs 1996; 52 (Suppl. 2): 55-61
(Type IV evidence - statistical information)
9b. Pulmonary rehabilitation is of benefit to many patients in that it improves exercise tolerance and quality of life, at least in the short term i.
(Health gain notation - 1 "beneficial")
caveat: A longer term study is under way ii.
i. Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348: 1115-1119.
(Type I evidence - meta-analysis);
ii. Griffiths, Burr and Campbell. Ongoing Study. Contact Dr I Campbell (see contributors)
Top

Contents Home

Health Evidence Bulletins: Wales, Duthie Library, UWCM, Cardiff CF14 4XN. e-mail: weightmanal@cardiff.ac.uk